Yang Guo

Yang Guo

Auto-generated profile, based on publicly available information

Yang Guo

Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, Jiangsu, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YTYuanyuan Tu
Yuanyuan Tu
LLLele Li
Lele Li
LZLinling Zhu
Linling Zhu
YGYang Guo
Yang Guo
SDShu Du
Shu Du
MZManhui Zhu
Manhui Zhu
Geniposide (GEN) is a natural antioxidant and anti‐inflammatory product and plays an important role in the treatment of diabetes and diabetic complications. To explore the biological functions and mechanism of GEN in diabetic retinopathy (DR), we constructed the in vitro and in vivo model of DR by using primary cultured mouse retinal Müller cells and C57BL/6 mice, respectively. We found that GEN inhibited ROS accumulation, NF‐κB activation, Müller cell activation, and inflammatory cytokine secretion both in vitro and in vivo, which is probably mediated through the Nrf2 pathway. Exendin (9‐39) (EX‐9), an antagonist of glucagon‐like peptide‐1 receptor (GLP‐1R), abolished the protective effect of GEN on high glucose‐ (HG‐) induced Müller cells. Additionally, GEN decreased hyperglycemia‐induced damage to Müller cells and blood‐retinal barrier in the retinas of mice with DR. We demonstrated that GEN was capable of protecting Müller cells and mice from HG‐induced oxidative stress and inflammation, which is mostly dependent on the Nrf2 signaling pathway through GLP‐1R. GEN may be an effective approach for the treatment of DR.